SCHEMBL22090032

SCHEMBL22090032

Cc1cccc([N+](=O)[O-])c1Nc1ncc(O)c(C#N)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNMA1 Q12791 1/20 0.44
▸ LCK P06239 1/20 0.38
▸ GSK3B P49841 1/20 0.37
▸ TSHR P16473 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CCNT1 O60563 2/20 0.36
▸ CDK1 P06493 2/20 0.36
▸ CCNB1 P14635 2/20 0.36
▸ CDK9 P50750 2/20 0.36
▸ CDK2 P24941 2/20 0.36
▸ CDK4 P11802 1/20 0.36
▸ STAT3 P40763 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CXCR2 P25025 1/20 0.36
▸ MAPT P10636 3/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22090143 0.85 MEN1 (0.35) GSK3BCCNT1CDK1CCNB1CDK9
SCHEMBL22089989 0.85 PTK2 (0.39) KCNMA1LCKGSK3BTSHRSMN1; SMN2
SCHEMBL18134016 0.77 TSHR (0.47) KCNMA1LCKGSK3BTSHRSMN1; SMN2
SCHEMBL18131712 0.74 TSHR (0.45) KCNMA1LCKGSK3BTSHRSMN1; SMN2
SCHEMBL15412383 0.74 TSHR (0.45) KCNMA1LCKGSK3BTSHRSMN1; SMN2
SCHEMBL30466489 0.74 TSHR (0.45) KCNMA1LCKGSK3BTSHRSMN1; SMN2
SCHEMBL21386640 0.74 SMN1; SMN2 (0.50) KCNMA1LCKTSHRSMN1; SMN2TDP1
SCHEMBL18131701 0.72 TSHR (0.43) KCNMA1LCKGSK3BTSHRSMN1; SMN2
SCHEMBL18131743 0.72 TSHR (0.42) KCNMA1LCKGSK3BTSHRSMN1; SMN2
SCHEMBL16665294 0.72 TSHR (0.42) KCNMA1LCKTSHRSMN1; SMN2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020119606-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR GUANGDONG NEWOPP BIOPHARMACEUTICALS CO., LTD. (CN) 2020-06-18 — — WO disclosed
Send feedback